Vifor Pharma AG (XSWX:VIFN) Net Issuance of Preferred Stock : CHF0 Mil (TTM As of Dec. 2021)

View and export this data going back to 2003. Start your Free Trial

What is Vifor Pharma AG Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Vifor Pharma AG's net issuance of preferred for the six months ended in Dec. 2021 was CHF0 Mil. The number is 0, which means that Vifor Pharma AG has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Vifor Pharma AG's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2021 was CHF0 Mil.

Vifor Pharma AG Net Issuance of Preferred Stock Historical Data

The historical data trend for Vifor Pharma AG's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG Net Issuance of Preferred Stock Chart

Vifor Pharma AG Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Vifor Pharma AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Vifor Pharma AG Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0 Mil.

Vifor Pharma AG Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Vifor Pharma AG (XSWX:VIFN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (XSWX:VIFN) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rechenstrasse 37, Saint Gallen, CHE, 9014

Website

https://www.viforpharma.com

Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (XSWX:VIFN) Headlines

No Headlines